Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Michael E. Kelly MD, PhD

Michael E. Kelly MD, PhD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Oncology

Member of the Cancer Center

Research Experience

  • Leukemia
  • Vascular Neoplasms
  • Clinical Expertise

  • Hemangioma
  • Leukemia
  • Neoplasms, Vascular Tissue
  • Publications

  • Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. (Chiu YE, Drolet BA, Blei F, Carcao M, Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, Recht M, Silverman RA, Tom WL, Pope E) Pediatr Blood Cancer 2012 Nov;59(5):934-8 PMID 22648868
  • Endoscopic management of gastrointestinal bleeding from multifocal lymphangioendotheliomatosis with thrombocytopenia: limited efficacy and complications. (Noel RJ, Duffy KJ, Kelly ME, Tondravi N, North PE, Drolet BA) J Pediatr Gastroenterol Nutr 2012 Jun;54(6):822-4 PMID 21788915
  • Microcystic adnexal carcinoma: the first reported congenital case. (Smart DR, Taintor AR, Kelly ME, Lyon VB, Segura A, Jensen JN, Drolet BA) Pediatr Dermatol 2011 Jan-Feb;28(1):35-8 PMID 21276051
  • Kasabach-Merritt phenomenon. (Kelly M) Pediatr Clin North Am 2010 Oct;57(5):1085-9 PMID 20888459
  • Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas. (Kelly ME, Juern AM, Grossman WJ, Schauer DW, Drolet BA) Arch Dermatol 2010 Jul;146(7):767-74 PMID 20479291
  • Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. (Maronn M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M) Pediatr Blood Cancer 2009 Apr;52(4):531-4 PMID 19058203
  • Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report. (Cameron C, Greenbaum L, Sato T, Trost B, Lundeen B, Kelly ME) Pediatr Nephrol 2008 Jul;23(7):1167-70 PMID 18286306
  • Measuring fatigue for children with cancer: development and validation of the pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (pedsFACIT-F). (Lai JS, Cella D, Kupst MJ, Holm S, Kelly ME, Bode RK, Goldman S) J Pediatr Hematol Oncol 2007 Jul;29(7):471-9 PMID 17609625
  • Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. (Rao A, Kelly M, Musselman M, Ramadas J, Wilson D, Grossman W, Shenoy S) Pediatr Blood Cancer 2008 Apr;50(4):822-5 PMID 17570702
  • Successful umbilical cord blood stem cell transplantation in a patient with Rothmund-Thomson syndrome and combined immunodeficiency. (Broom MA, Wang LL, Otta SK, Knutsen AP, Siegfried E, Batanian JR, Kelly ME, Shah M) Clin Genet 2006 Apr;69(4):337-43 PMID 16630167
  • Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. (Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, Truong N, Chatila TA) Clin Immunol 2005 Dec;117(3):231-7 PMID 16169277
  • Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features. (Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M) Radiology 2000 Oct;217(1):16-25 PMID 11012419
  • High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis. (Cohen AH, Sweet SC, Mendeloff E, Mallory GB Jr, Huddleston CB, Kraus M, Kelly M, Hayashi R, DeBaun MR) Am J Respir Crit Care Med 2000 Apr;161(4 Pt 1):1252-5 PMID 10764320
  • Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. (Mistry MJ, Clay MA, Kelly ME, Steiner MA, Harmony JA) Cell Immunol 1995 Jan;160(1):14-23 PMID 7842480
  • Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. (Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JA) Cell Immunol 1994 Dec;159(2):124-39 PMID 7994749
  • alpha-Difluoromethylornithine induces differentiation of a human embryonal carcinoma cell line in vitro. (Uhl L, Kelly M, Schindler J) Biochem Biophys Res Commun 1986 Oct 15;140(1):66-73 PMID 3096321
  • Alterations in polyamine metabolism during embryonal carcinoma cell differentiation in vitro. (Kelly M, McCann PP, Schindler J) Dev Biol 1985 Oct;111(2):510-4 PMID 3930315
  • The response of several murine embryonal carcinoma cell lines to stimulation of differentiation by alpha-difluoromethylornithine. (Schindler J, Kelly M, McCann PP) J Cell Physiol 1985 Jan;122(1):1-6 PMID 3917438
  • Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation. (Schindler J, Kelly M, McCann PP) Biochem Biophys Res Commun 1983 Jul 18;114(1):410-7 PMID 6411082
  • Last update: 05/20/2015